LFCR Lifecore Biomedical Inc
551
$6.87
$0.21
(3.15%)
| Watchers | 551 |
| 52-Wk Low | $4.13 |
| 52-Wk High | $11.46 |
| Market Cap | $203.44M |
| Volume | 207,390.00 |
| 52-Wk High | $11.46 |
| 52-Wk Low | $4.13 |
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCPR Newswire • 2 days ago
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC ROSEN, A HIGHLY...
Share to Feed
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC ROSEN, NATIONAL INVESTOR...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC ROSEN, SKILLED INVESTOR...
LFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors...
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lifecore Biomedical Inc. f/k/a Landec Corporation...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors...
Year-to-date Results Consistent with Prior Expectations; Experiencing Fiscal Second Half Lift Provides Fiscal 2024 Full Year Guidance Commercial Momentum Continues within Development Portfolio...
Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Lifecore Biomedical, Inc. (Lifecore or the...